Abstract

The University of California, Irvine, College of Medicine has been a member of the Gynecologic Oncology Group since 1977. The Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, College of Medicine, University of California, Irvine and its affiliated hospitals will conduct the clinical studies. The institutions involved in the accession of patients to protocols will be: California College of Medicine, University of California, Irvine Department of OB/GYN, Orange, California Women's Hospital, Memorial Hospital Medical Center Long Beach, California Kaiser Permanente Medical Group Hollywood, California The City of Hope National Medical Center Duarte, California Our institution will register all new gynecological cancer patients entering our hospitals with the Group operations office and will participate in all Group studies.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
3U10CA023765-10S2
Application #
3556705
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1984-07-01
Project End
1989-06-30
Budget Start
1987-05-01
Budget End
1989-06-30
Support Year
10
Fiscal Year
1989
Total Cost
Indirect Cost

  Institution

Name
University of California Irvine
Department
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697

  Publications

Sutton, Gregory; Axelrod, Janice H; Bundy, Brian N et al. (2006) Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 100:349-54
Tate Thigpen, J; Blessing, John A; DeGeest, Koen et al. (2004) Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study. Gynecol Oncol 93:336-9
Thigpen, J Tate; Blessing, John A; Olt, George et al. (2003) Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study. Gynecol Oncol 90:581-6
Keys, Henry M; Bundy, Brian N; Stehman, Frederick B et al. (2003) Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol 89:343-53
Spirtos, Nick M; Westby, Cynthia M; Averette, Hervy E et al. (2002) Blood transfusion and the risk of recurrence in squamous cell carcinoma of the cervix: a gynecologic oncology group study. Am J Clin Oncol 25:398-403
Zaino, R; Whitney, C; Brady, M F et al. (2001) Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol 83:355-62
McGuire, W P; Hoskins, W J; Brady, M F et al. (1995) Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 13:1589-99
Eddy, G L; Manetta, A; Alvarez, R D et al. (1995) Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. Gynecol Oncol 57:412-6
Horowitz, M E; Pratt, C B; Webber, B L et al. (1986) Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcoma: a review of 62 cases treated at a single institution. J Clin Oncol 4:559-64
Abdulhay, G; DiSaia, P J; Blessing, J A et al. (1985) Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: a Gynecologic Oncology Group Study. Am J Obstet Gynecol 152:418-23

Showing the most recent 10 out of 11 publications